Tags

Type your tag names separated by a space and hit enter

Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature.
Pharmacopsychiatry 1989; 22(5):174-82P

Abstract

Although it might be premature to consider the efficacy of lithium addition in patients unresponsive to conventional antidepressant drug treatment as established, the evidence is suggestive. Besides 26 open studies, four out of six controlled investigations reported a positive effect of combined therapy administered in the indicated sequence. Three controlled studies confirmed the original observation of de Montigny et al. that improvement may occur within 48 hours. Successful lithium addition was reported in different types of depression and after pretreatment with tricyclic antidepressants, related compounds or MAO-inhibitors. Preliminary recommendations with respect to the practical use of lithium addition are made.

Authors+Show Affiliations

Psychiatrische Universitätsklinik Zürich, Switzerland.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

2682691

Citation

Schöpf, J. "Treatment of Depressions Resistant to Tricyclic Antidepressants, Related Drugs or MAO-inhibitors By Lithium Addition: Review of the Literature." Pharmacopsychiatry, vol. 22, no. 5, 1989, pp. 174-82.
Schöpf J. Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature. Pharmacopsychiatry. 1989;22(5):174-82.
Schöpf, J. (1989). Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature. Pharmacopsychiatry, 22(5), pp. 174-82.
Schöpf J. Treatment of Depressions Resistant to Tricyclic Antidepressants, Related Drugs or MAO-inhibitors By Lithium Addition: Review of the Literature. Pharmacopsychiatry. 1989;22(5):174-82. PubMed PMID: 2682691.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature. A1 - Schöpf,J, PY - 1989/9/1/pubmed PY - 1989/9/1/medline PY - 1989/9/1/entrez SP - 174 EP - 82 JF - Pharmacopsychiatry JO - Pharmacopsychiatry VL - 22 IS - 5 N2 - Although it might be premature to consider the efficacy of lithium addition in patients unresponsive to conventional antidepressant drug treatment as established, the evidence is suggestive. Besides 26 open studies, four out of six controlled investigations reported a positive effect of combined therapy administered in the indicated sequence. Three controlled studies confirmed the original observation of de Montigny et al. that improvement may occur within 48 hours. Successful lithium addition was reported in different types of depression and after pretreatment with tricyclic antidepressants, related compounds or MAO-inhibitors. Preliminary recommendations with respect to the practical use of lithium addition are made. SN - 0176-3679 UR - https://www.unboundmedicine.com/medline/citation/2682691/Treatment_of_depressions_resistant_to_tricyclic_antidepressants_related_drugs_or_MAO_inhibitors_by_lithium_addition:_review_of_the_literature_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-1014602 DB - PRIME DP - Unbound Medicine ER -